I agree with those sentiments very much. I also believe the licensing of Pimd will help to some extent as well on the bottom line figures. How much I have no idea but it will save the outlay of cash from buying from other vendors. We shall see.


I believe even if #s are not as robust then they were averaging approx 5m, it's far healthier as a compant to now have 3 business segments and to show diversification. Again, lets see how the #s for Main Ave play out over the next 3 to 4 months. If Pimd can show some further strength as well as the diabetic program scrc as a company will be in much better shape with atleast 2 of the 3 segments being profitable right now. I believe Bob S ststed on his radio show that Pimd is profitable so we did 137k last month in revenues we can use that as some sort of benchmark. I like his phrase that the diabetic program is humming thats a very big positive.


Conclusion: We now have a much more diversified company and if we are able to become profitable with the diabetic program then having 3 profitable segments is far better than just having 1 even if the #s at Main Ave are a little less. Again, I would like to see the evidence with Main Ave over the next 3 to 4 months where the #s go as my understanding deductibles is part of Jan and Feb so I want to see how this plays out for April's #s with Main Ave.